Asio Capital, LLC Abb Vie Inc. Transaction History

Asio Capital, LLC

$507 Million
Q3 2024

A detailed history of Asio Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Asio Capital, LLC holds 5,079 shares of ABBV stock, worth $872,216. This represents 0.2% of its overall portfolio holdings.

Number of Shares

5,079

Previous 5,105 0.51%

Holding current value

$872,216

Previous $875,000 14.63%

% of portfolio

0.2%

Previous 0.18%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$163.84 - $199.33 $4,259 - $5,182	-26 Reduced 0.51%	5,079 $1 Million
Q2 2024 Jul 17, 2024	SELL	$154.79 - $180.76 $773 - $903	-5 Reduced 0.1%	5,105 $875,000
Q1 2024 Apr 16, 2024	BUY	$159.82 - $182.1 $5,593 - $6,373	35 Added 0.69%	5,110 $930,000
Q4 2023 Jan 11, 2024	SELL	$137.6 - $154.97 $1,376 - $1,549	-10 Reduced 0.2%	5,075 $786,000
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $1 Million - $1.16 Million	-7,492 Reduced 59.57%	5,085 $757,000
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $1.67 Million - $2.07 Million	-12,569 Reduced 49.98%	12,577 $1.69 Million
Q1 2023 Apr 24, 2023	BUY	$144.61 - $166.54 $56,108 - $64,617	388 Added 1.57%	25,146 $4.01 Million
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $7,053 - $8,459	-51 Reduced 0.21%	24,758 $0
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $611,326 - $701,151	-4,555 Reduced 15.51%	24,809 $3.33 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $24,358 - $30,967	177 Added 0.61%	29,364 $4.5 Million
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $1.4 Million - $1.73 Million	-10,576 Reduced 26.6%	29,187 $4.73 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $126,874 - $160,533	1,181 Added 3.06%	39,763 $5.38 Million
Q3 2021 Nov 01, 2021	BUY	$106.4 - $120.78 $159,280 - $180,807	1,497 Added 4.04%	38,582 $4.16 Million
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $228,095 - $254,111	2,168 Added 6.21%	37,085 $4.18 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $693,696 - $763,676	6,781 Added 24.1%	34,917 $3.78 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $136,028 - $183,652	1,690 Added 6.39%	28,136 $3.02 Million
Q3 2020 Oct 15, 2020	BUY	$85.91 - $100.83 $531,181 - $623,431	6,183 Added 30.51%	26,446 $2.32 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $264,352 - $353,742	3,603 Added 21.63%	20,263 $1.99 Million
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $1.07 Million - $1.63 Million	16,660 New	16,660 $1.27 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asio Capital, LLC with notifications on news.

Account